The current valuation score of Quoin Pharmaceuticals Ltd is 7.16, ranking 265 out of 368 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.72, which is -15337.02% below the recent high of 109.97 and -898774.81% above the recent low of -6487.18.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.